微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -0.73% | 78.53% | 47.1% | 104/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -1.38% | -305.97% | 86.58% | 117/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -10.28% | -4.68% | -467.96% | 121/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -1.81% | 68.95% | 46.76% | 116/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -3.4% | -65.05% | -607.46% | 123/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.67% | 116.03% | 106.82% | 84/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -9.82% | -161.87% | -68.44% | 122/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -5.83% | -276.13% | -183.01% | 122/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -2.06% | -331.46% | 50.72% | 121/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -4.18% | -1406.25% | -11.47% | 123/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -3.75% | -106.57% | -213.29% | 114/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.31% | -93.86% | 271.91% | 85/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.89% | -97.72% | 178.13% | 103/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.32% | -98.44% | -99.44% | 103/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 57.09% | -7.4% | 5.9% | 4/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 53.91% | 18.12% | 38.3% | 5/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 38.98% | 27.39% | 90.05% | 6/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 20.51% | -12.16% | -66.73% | 11/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 61.65% | -20.48% | 35.08% | 5/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 45.64% | -22.5% | 49.15% | 8/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 30.6% | -10.89% | 31.05% | 7/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 23.35% | 142.47% | -69.88% | 6/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 77.53% | 11827.69% | 31.65% | 13/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 58.89% | 1263.19% | 71.49% | 7/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 34.34% | 1092.36% | 256.59% | 15/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 9.63% | 525.32% | 1381.54% | 6/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 0.65% | -75.56% | -84.95% | 107/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.32% | -4.21% | 50% | 54/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.88% | -0.69% | 87.01% | 54/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.54% | -3.75% | -42.11% | 35/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.66% | -19.88% | -41.02% | 92/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.51% | -3.43% | 55.52% | 43/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 2.9% | 11.54% | 81.25% | 43/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.6% | -4.19% | -51.81% | 35/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 3.32% | -34.52% | -28.91% | 89/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 4.67% | -24.92% | 79.62% | 37/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 2.6% | -24.64% | 55.69% | 47/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.67% | -16.5% | -67.06% | 33/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 5.07% | -21.52% | -18.49% | 69/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.22% | -30.43% | 80.29% | 24/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 3.45% | -37.5% | 72.5% | 35/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2% | -32.2% | -69.04% | 18/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |